SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-041838
Filing Date
2021-10-28
Accepted
2021-10-28 12:55:17
Documents
1
Period of Report
2021-10-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 19398
  Complete submission text file 0000899243-21-041838.txt   21360
Mailing Address 71 KINGSWAY LONDON X0 WC2B 6ST
Business Address 71 KINGSWAY LONDON X0 WC2B 6ST 44 20 7421 7081
SV7 Impact Medicine Fund LP (Reporting) CIK: 0001780602 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 211356613

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 71 KINGSWAY LONDON X0 WC2B 6ST
Business Address 71 KINGSWAY LONDON X0 WC2B 6ST 44 20 7421 7081
SV7 (IMF) GP LLP (Reporting) CIK: 0001889859 (see all company filings)

State of Incorp.: X0
Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 211356612